Efg Asset Management (North America) Corp. Halozyme Therapeutics, Inc. Transaction History
Efg Asset Management (North America) Corp.
- $566 Million
- Q2 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 140,269 shares of HALO stock, worth $7.94 Million. This represents 1.3% of its overall portfolio holdings.
Number of Shares
140,269
Previous 140,089
0.13%
Holding current value
$7.94 Million
Previous $5.7 Million
28.89%
% of portfolio
1.3%
Previous 1.0%
Shares
11 transactions
Others Institutions Holding HALO
# of Institutions
488Shares Held
122MCall Options Held
208KPut Options Held
66.3K-
Black Rock Inc. New York, NY17.6MShares$998 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$730 Million0.01% of portfolio
-
State Street Corp Boston, MA5.81MShares$329 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.04MShares$229 Million4.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.72MShares$211 Million0.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.89B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...